Frank Zexi Chen

Title: Frank Zexi Chen: Innovator in Clinical Trial Technologies

Introduction

Frank Zexi Chen is a notable inventor based in Forest Hills, NY (US). He has made significant contributions to the field of clinical trials through his innovative patents. With a total of 2 patents, Chen is recognized for his work in developing systems that enhance patient participation in clinical trials.

Latest Patents

Chen's latest patents include a "Clinical trial matching system using inferred biomarker status." This invention involves a model-assisted system designed to identify a group of patients for a cohort using a generalized biomarker model. The system is programmed to provide a first biomarker associated with a cohort and to receive outputs indicating individuals' likelihoods of having certain attributes. This innovative approach aims to streamline the process of patient selection for clinical trials.

Another significant patent is "Systems and methods for providing clinical trial status information for patients." This invention features a graphical user interface that displays an electronic medical record associated with a patient. The interface includes an area for patient information and an indicator that specifies the patient's eligibility or participation status in clinical trials. This technology enhances communication and transparency regarding clinical trial opportunities for patients.

Career Highlights

Frank Zexi Chen is currently employed at Flatiron Health, Inc., where he continues to develop innovative solutions in the healthcare sector. His work focuses on improving the efficiency and effectiveness of clinical trials, ultimately benefiting patient care and research outcomes.

Collaborations

Chen collaborates with talented professionals in his field, including Lauren Sutton and David Light. These partnerships contribute to the advancement of clinical trial technologies and foster a collaborative environment for innovation.

Conclusion

Frank Zexi Chen is a distinguished inventor whose work in clinical trial technologies has the potential to transform patient engagement in medical research. His innovative patents reflect a commitment to improving healthcare outcomes through technology.